|
Volumn 23, Issue 2, 2013, Pages 569-573
|
Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors
|
Author keywords
catenin; Phenylaminopyridine; TCF4; TNIK; Wnt signaling
|
Indexed keywords
4 PHENYL 2 PHENYLAMINOPYRIDINE DERIVATIVE;
AMINOPYRIDINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
BETA CATENIN;
BETA LACTAMASE;
ENZYME INHIBITOR;
PHOSPHOTRANSFERASE;
STAUROSPORINE;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR TCF4;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2 AND NCK INTERACTIVE KINASE;
UNCLASSIFIED DRUG;
WNT PROTEIN;
ARTICLE;
CANCER CELL;
CELL PROLIFERATION;
CELL VIABILITY;
COLORECTAL CANCER;
COMPLEX FORMATION;
CONTROLLED STUDY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GENETIC TRANSCRIPTION;
MOLECULAR STABILITY;
SIGNAL TRANSDUCTION;
AMINOPYRIDINES;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CELL SURVIVAL;
COLORECTAL NEOPLASMS;
DRUG DISCOVERY;
ENZYME ACTIVATION;
HUMANS;
INHIBITORY CONCENTRATION 50;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PROTEIN-SERINE-THREONINE KINASES;
SIGNAL TRANSDUCTION;
|
EID: 84871718156
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.11.013 Document Type: Article |
Times cited : (23)
|
References (20)
|